CF
EMN icon

Concorde Financial’s Eastman Chemical EMN Stock Holding History

Concorde Financial’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,676
Closed -$1.18M – 30
2025
Q3 		$1.18M Sell
18,676
-3,885
-17% -$271K 0.65% 33
2025
Q2 		$1.68M Buy
22,561
+211
+0.9% +$16.6K 1% 31
2025
Q1 		$1.97M Buy
22,350
+534
+2% +$50.4K 1.09% 31
2024
Q4 		$1.99M Buy
21,816
+374
+2% +$38.4K 1.19% 30
2024
Q3 		$2.42M Buy
+21,442
New +$2.14M 1.42% 30

Other funds holding EMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concorde Financial's EMN Position: Q4 2025 in Review

Concorde Financial sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 18,676 shares — an estimated $1.18M sold.

Concorde Financial first reported a position in EMN in Q3 2024 and held it in 5 quarters. The position peaked at $2.42M in Q3 2024. 630 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Concorde Financial reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • Concorde Financial sold 18,676 Eastman Chemical shares in Q4 2025, an estimated $1.18M.
  • Concorde Financial first reported a position in Eastman Chemical in Q3 2024 and held it in 5 quarters.
  • Concorde Financial's Eastman Chemical position peaked at $2.42M in Q3 2024.
  • 630 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Concorde Financial's 13F filing for Q4 2025, filed 17 Feb 2026.